Position in BIIB
as of Mar 31, 2026
· filed May 12, 2026
Position Value
$129,100,252
+$5,168,798 QoQ
Shares Held
704,196
0.0% QoQ
Ownership
0.477%
of shares outstanding
% of Portfolio
0.99%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in BIIB Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026Employees Provident Fund Board holds $1,134,862,339 across 8 Drug Manufacturers - General names. BIIB ranks #4 (11.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
524,361 | $482,291,516 | |
| 2 | MRK |
Merck & Co., Inc.
|
1,895,165 | $227,969,397 | |
| 3 | BMY |
Bristol Myers Squibb Co
|
2,509,000 | $152,170,850 | |
| 4 | BIIB |
Biogen Inc.
This page
|
704,196 | $129,100,252 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
346,000 | $48,222,020 | |
| 6 | JNJ |
Johnson & Johnson
|
182,381 | $44,581,211 | |
| 7 | ABBV |
AbbVie Inc.
|
145,134 | $31,565,193 | |
| 8 | AMGN |
Amgen Inc
|
53,892 | $18,961,900 |
All Filings in BIIB
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $129,100,252 | 704,196 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $123,931,454 | 704,196 | Shares | Sole | 2026-03-03 | |
| 2025-09-30 | $98,643,775 | 704,196 | Shares | Sole | 2026-03-17 | |
| 2025-06-30 | $88,439,975 | 704,196 | Shares | Sole | 2026-03-17 | |
| 2025-03-31 | $96,362,180 | 704,196 | Shares | Sole | 2026-03-17 | |
| 2024-12-31 | $107,685,652 | 704,196 | Shares | Sole | 2026-03-17 | |
| 2024-09-30 | $131,439,027 | 678,080 | Shares | Sole | 2026-03-17 | |
| 2024-06-30 | $157,192,505 | 678,080 | Shares | Sole | 2026-03-18 | |
| 2024-03-31 | $146,214,390 | 678,080 | Shares | Sole | 2026-03-18 | |
| 2023-12-31 | $146,016,924 | 564,273 | Shares | Sole | 2026-03-18 | |
| 2023-09-30 | $113,705,336 | 442,416 | Shares | Sole | 2026-03-18 | |
| 2023-06-30 | $81,894,375 | 287,500 | Shares | Sole | 2026-03-31 | |
| 2023-03-31 | $95,920,350 | 345,000 | Shares | Sole | 2026-03-18 | |
| 2022-12-31 | $95,537,400 | 345,000 | Shares | Sole | 2026-03-18 | |
| 2022-09-30 | $104,845,560 | 392,680 | Shares | Sole | 2026-03-18 | |
| 2022-06-30 | $80,083,159 | 392,680 | Shares | Sole | 2026-03-18 | |
| 2022-03-31 | $74,829,970 | 355,318 | Shares | Sole | 2026-03-18 | |
| 2021-12-31 | $50,999,554 | 212,569 | Shares | Sole | 2026-03-18 | |
| 2021-09-30 | $60,154,901 | 212,569 | Shares | Sole | 2026-03-18 | |
| 2021-06-30 | $73,606,267 | 212,569 | Shares | Sole | 2026-03-18 | |
| 2021-03-31 | $56,528,802 | 202,069 | Shares | Sole | 2026-03-18 | |
| 2020-12-31 | $49,478,615 | 202,069 | Shares | Sole | 2026-03-18 | |
| 2020-09-30 | $46,341,964 | 163,360 | Shares | Sole | 2026-03-20 | |
| 2020-06-30 | $43,706,968 | 163,360 | Shares | Sole | 2026-03-31 | |
| 2020-03-31 | $10,088,092 | 31,886 | Shares | Sole | 2026-03-20 | |
| No filing history on record for this holder in this stock. | ||||||